Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY) a regenerative medicine company specializing in the treatment of wounds and skin defects, announced today that the first patient has been enrolled in the Company’s Pivotal Phase III burn trial for ReCell®.
A new smart inhaler developed by respiratory technology company Nexus6 has been demonstrated to encourage child asthmatics to take medication.
Read more about Smart inhaler helps asthmatic kids breathe easier
Nexvet, which is developing biologics for the treatment of pain and inflammation in cats and dogs, filed on Tuesday with the SEC to raise up to $60 million in an initial public offering. The Dublin, Ireland-based company, which was founded in 2010, plans to list on the NASDAQ under the symbol NVET.
A physiotherapy service in Northamptonshire is giving people the chance to walk again with the world’s first self-supporting robotic exoskeleton.
Nicholas Fearon, known as ‘Pikki’, is a London-based film producer. With the support of the REX robot, Pikki will walk for the first time since he battled back from life threatening injuries he sustained in an accident 11 years ago. He was told by doctors he would never walk again – but the suit is helping him prove them wrong.
Read more about RXB – Robotic suit helps paralysed film director walk again
December 2014 – link here.
Read more about Nexvet December 2014 Newsletter – Paws for Thought
AmpliPhi BioSciences Corporation (OTCQB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, provided an update to shareholders during a teleconference on January 5, 2015.
Read more about AmpliPhi Provides Shareholder Update